Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)-real world experience from the US multiple myeloma immunotherapy consortium.
Saved in:
| Title: | Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)-real world experience from the US multiple myeloma immunotherapy consortium. |
|---|---|
| Authors: | Varga C; Levine Cancer Institute/Atrium Health, Charlotte, NC, USA. Cindy.varga@advocatehealth.org., Robinson M; Levine Cancer Institute/Atrium Health, Charlotte, NC, USA., Davis JA; Medical University of South Carolina, Charleston, SC, USA., Hashmi H; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Martin TG; University of California San Francisco Helen Diller Comprehensive Cancer Center, San Francisco, CA, USA., Kumar A; University of California San Francisco Helen Diller Comprehensive Cancer Center, San Francisco, CA, USA., Sborov DW; Huntsman Cancer Institute / University of Utah, Salt Lake City, UT, USA., Wagner CB; Huntsman Cancer Institute / University of Utah, Salt Lake City, UT, USA., Hansen DK; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Castaneda Puglianini O; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Shune L; University of Kansas Medical Center, Kansas City, KS, USA., Bhurtel E; University of Kansas Medical Center, Kansas City, KS, USA., Afrough A; Simmons Comprehensive Cancer Center at UT Southwestern Medical Center, Dallas, TX, USA., Anderson LD Jr; Simmons Comprehensive Cancer Center at UT Southwestern Medical Center, Dallas, TX, USA., Dhakal B; Medical College of Wisconsin, Milwaukee, WI, USA., Herr MM; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Richard S; ICAHN School of Medicine at Mount Sinai, New York, NY, USA., Lieberman-Cribbin A; ICAHN School of Medicine at Mount Sinai, New York, NY, USA., Sherbenou D; University of Colorado Comprehensive Cancer Center, Aurora, CO, USA., Forsberg PA; University of Colorado Comprehensive Cancer Center, Aurora, CO, USA., Purvey S; Virginia Commonwealth University, Richmond, VA, USA., Khouri J; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA., Lin Y; Mayo Clinic Comprehensive Cancer Center, Rochester, USA., Sidana S; Stanford University School of Medicine, Stanford, CA, USA., Patel KK; The University of Texas MD Anderson Cancer Center, Houston, USA., Kocoglu M; University of Maryland Marlene and Stewart Greenbaum Comprehensive Cancer Center, Baltimore, MD, USA., Midha S; Dana Farber Cancer Institute, Boston, MA, USA., Ferreri CJ; Levine Cancer Institute/Atrium Health, Charlotte, NC, USA. |
| Source: | Blood cancer journal [Blood Cancer J] 2026 Mar 20; Vol. 16 (1). Date of Electronic Publication: 2026 Mar 20. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2044-5385 |
|---|---|
| DOI: | 10.1038/s41408-026-01469-z |
